Mind-Body Program for Cancer Patients

Evaluation of Mind-Body Groups on the Quality of Life of Cancer Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00179387

Enrollment

166

Registered

2005-09-16

Start date

2004-12-01

Completion date

2016-02-25

Last updated

2023-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

Neoplasms, Needs Assessment, Adaptation Psychological, Minority Groups, Psychotherapy, Group, Program Evaluation, Spirituality, Spiritual Therapies

Brief summary

The purpose of this study is to find out if Mind-Body groups can help improve the physical and emotional well-being of people facing cancer or its treatment.

Detailed description

Pain, fatigue, anxiety, depression, nausea, sexual impairment, body image disturbance, relationship strains, existential distress and role losses are all potential side-effects of living with cancer and its treatment. Behavioral interventions have shown some success in mitigating distress and QOL impairment among cancer patients. The purpose of this randomized-controlled study is to compare the effects of Mind-body group interventions on the quality of life of patients with advanced cancer. Patients are randomized to one of two psychotherapy groups, which occur weekly for eight weeks. Quality of life assessments are conducted at baseline and two and four-month intervals.

Interventions

BEHAVIORALMind-Body Psychotherapy Group

Psycho-educational group

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* On Active Treatment for: Breast Cancer Stage IV, Colorectal Cancer Stage IV, Lung Cancer Stages III & IV, or All Other Cancers (ANY stage on treatment) * Language is English or Spanish

Exclusion criteria

* Patient is currently attending other support/psychotherapy group * Significant Cognitive Impairment * ECOG performance status = 3 or 4 * Current major untreated psychiatric disorder * Unable to attend intervention in following 8 weeks due to medical or practical restrictions

Design outcomes

Primary

Measure	Time frame
Functional Assessment of Cancer Therapy	baseline to 2 months and 4 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026